hydrochlorothiazide has been researched along with endothelin-1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benedetti, G; Benigni, A; Bruzzi, I; Corna, D; Noris, M; Remuzzi, G; Todeschini, M; Zoja, C | 1 |
| Crespo, MJ; De Mello, WC | 1 |
2 other study(ies) available for hydrochlorothiazide and endothelin-1
| Article | Year |
|---|---|
Renoprotection by nitric oxide donor and lisinopril in the remnant kidney model.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Creatinine; Disease Progression; Eating; Endothelin-1; Hydralazine; Hydrochlorothiazide; Kidney; Lisinopril; Male; Molsidomine; Nephrectomy; Nitric Oxide; Nitric Oxide Donors; Nitrous Oxide; Rats; Rats, Sprague-Dawley; Reserpine | 1999 |
Chronic administration of losartan plus hydrochlorothiazide improves vascular status in young cardiomyopathic hamsters.
Topics: Acetylcholine; Animals; Antihypertensive Agents; Aorta, Thoracic; Body Weight; Cardiomyopathies; Cricetinae; Dose-Response Relationship, Drug; Drug Synergism; Endothelin-1; Endothelium, Vascular; Hydrochlorothiazide; In Vitro Techniques; Losartan; Male; Mesocricetus; Myocardium; Nitric Oxide; Organ Size; Peptidyl-Dipeptidase A; Vasoconstriction; Vasodilation; Vasodilator Agents | 2001 |